Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04933890 · ClinicalTrials.gov registry record
Detection of Heart Conditions Using Artificial Intelligence
A clinical trial, sponsored by Eko Devices.
- Completed
- Registry status
- 68
- Enrollment target
NCT04933890 is a clinical trial that has completed, run by Eko Devices. The registered enrollment target is 68 participants.
The verdict
NCT04933890 has completed, sponsored by Eko Devices.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how Eko AI performs in the real world, front-line setting where the availability of sophisticated, expensive diagnostic tools is limited, and where there is a premium on detecting VHD early in its course.
Interventions
- DEVICE Use of Eko DUO electronic stethoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2021-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04933890
The ClinicalTrials.gov registry entry for NCT04933890 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eko Devices, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Use of Eko DUO electronic stethoscope is the first listed.
NCT04933890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04933890 about?
NCT04933890 is a clinical study titled "Detection of Heart Conditions Using Artificial Intelligence". The purpose of this study is to evaluate how Eko AI performs in the real world, front-line setting where the availability of sophisticated, expensive diagnostic tools is limited, and where there is a premium on detecting VHD early in its course.
What is the current status of trial NCT04933890?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2021-06-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04933890?
The interventions under investigation include: Use of Eko DUO electronic stethoscope (DEVICE).
Who is sponsoring clinical trial NCT04933890?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.